Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The androgen receptor (AR) is a key regulator of prostate growth and the principal drug target for the treatment of prostate cancer. Previous studies have mapped AR targets and identified some candidates which may contribute to cancer progression, but did not characterize AR biology in an integrated manner. In this study, we took an interdisciplinary approach, integrating detailed genomic studies with metabolomic profiling and identify an anabolic transcriptional network involving AR as the core regulator. Restricting flux through anabolic pathways is an attractive approach to deprive tumours of the building blocks needed to sustain tumour growth. Therefore, we searched for targets of the AR that may contribute to these anabolic processes and could be amenable to therapeutic intervention by virtue of differential expression in prostate tumours. This highlighted calcium/calmodulin-dependent protein kinase kinase 2, which we show is overexpressed in prostate cancer and regulates cancer cell growth via its unexpected role as a hormone-dependent modulator of anabolic metabolism. In conclusion, it is possible to progress from transcriptional studies to a promising therapeutic target by taking an unbiased interdisciplinary approach.

Original publication

DOI

10.1038/emboj.2011.158

Type

Journal article

Journal

EMBO J

Publication Date

20/05/2011

Volume

30

Pages

2719 - 2733

Keywords

Animals, Base Sequence, Binding Sites, Biosynthetic Pathways, Carcinoma, Cell Line, Tumor, Cell Proliferation, Cluster Analysis, Gene Expression Regulation, Neoplastic, Humans, Male, Metabolism, Mice, Models, Biological, Prostatic Neoplasms, Receptors, Androgen, Response Elements, Transplantation, Heterologous